The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemic

Author:

Roque Katia1234ORCID,Ruiz Rossana15ORCID,Otoya-Fernandez Iris1ORCID,Galarreta José67,Vidaurre Tatiana12ORCID,de Mello Ramon Andrade48ORCID,Neciosup Silvia19ORCID,Mas Luis19ORCID,Gómez Henry1910ORCID

Affiliation:

1. Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Angamos Este Av, 2520, Lima, Peru

2. Universidad Peruana Cayetano Heredia, Lima, Peru

3. Universidad Nacional Mayor de San Marcos, Lima, Peru

4. Pos graduation Program in Medicine, Nine of July University (UNINOVE), Sao Paulo, Brazil

5. Universidad Cientifica del Sur, Lima, Peru

6. Department of Telemedicine, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru

7. Department of Breast Cancer Surgery, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru

8. Division of Medical Oncology, Hospital Israelita Albert Eisten, Sao Paulo, Brazil

9. Department of Medical Oncology, Oncosalud-AUNA, Lima, Peru

10. Universidad Ricardo Palma, Lima, Peru

Abstract

Background: The COVID-19 pandemic caused discontinuities in cancer care (CC) in most countries. Here, the authors describe the real-world impacts of implementing a contingency plan employing telemedicine for CC. Methods: A retrospective study of patients who received CC through telemedicine at the Instituto Nacional de Enfermedades Neoplasicas, Peru, from March 2020 to February 2021 was conducted. Impacts were measured by comparing the amount of CC administered during the pandemic versus the prior year. Results: A total of 16,456 telemedicine visits were carried out. An annual comparative analysis showed a gap of 23% and telemedicine accounted for 27.6% of the total CC administered during the pandemic. A high (4.50/5) level of patient satisfaction with telemedicine was reported. Conclusion: Telemedicine is an important tool to facilitate the continuity of CC.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Reference30 articles.

1. WHO. World Health Statistics 2020: Monitoring Health for Sustainable Development Goals (SDGs) (2021). https://apps.who.int/iris/bitstream/handle/10665/332070/9789240005105-eng.pdf?sequence=1&isAllowed=y

2. COVID-19 in Immunocompromised Hosts: What We Know So Far

3. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

4. Could telemedicine solve the cancer backlog?

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3